Breaking News Instant updates and real-time market news.

ALXN

Alexion

$105.68

6.46 (6.51%)

12:40
10/23/19
10/23
12:40
10/23/19
12:40

Piper a buyer of Alexion after 'another quarter of flawless execution'

Piper Jaffray analyst Christopher Raymond said he remains a buyer of shares of Alexion following what he describes as "yet another beat/raise quarter with near flawless execution both commercially and developmentally." Despite similar results in the past several quarters, the stock "has languished," which Raymond attributes to what he views as overblown concerns regarding the tail trajectory for the company's C5 inhibitor franchise. However, Raymond contends that Ultomiris conversion is "well ahead of schedule," which the company is coupling "with an almost breathtaking pace of BD-driven pipeline diversification." He maintains an Overweight rating and $180 price target on Alexion shares.

  • 23

    Oct

  • 04

    Nov

  • 07

    Dec

ALXN Alexion
$105.68

6.46 (6.51%)

10/04/19
GUGG
10/04/19
NO CHANGE
GUGG
Guggenheim positively biased on Biotech heading into earnings
Guggenheim analysts Whitney Ijem, Etzer Darout, Yatin Suneja and Michael Schmidt offered a preview for their joint Biotech coverage ahead of the group's earnings reporting season. Biotech stocks continued their downward trend in the quarter amid negative market sentiment and the analysts think the bar for companies to raise 2019 guidance again may be a bit higher following increases in FY19 consensus estimates on the heels of strong Q2 earnings results. However, they are postively biased on the group and have confidence in FY19 guidance and estimates, the analysts said. They see Alexion (ALXN), Biogen (BIIB), Genmab (GMAB), GW Pharmaceuticals (GWPH), Incyte (INCY), Neurocrine (NBIX), Regeneron (REGN) and Seattle Genetics (SGEN) as well positioned relative to expectations, Ijem, Darout, Suneja and Schmidt tell investors.
10/16/19
PIPR
10/16/19
NO CHANGE
Target $180
PIPR
Overweight
Piper likes Alexion acquisition of Achillion, remains buyer of shares
Piper Jaffray analyst Christopher Raymond keeps an Overweight rating on Alexion Pharmaceuticals (ALXN) with a $180 price target after this morning's announced acquisition of Achillion Pharmaceuticals (ACHN). The deal brings in danicopan, an oral Factor D inhibitor, as combination therapy with Soliris for the treatment of paroxysmal nocturnal hemoglobinuria and monotherapy for C3 glomerulopathy, and ACH-5228, a second generation oral Factor D inhibitor, expected to enter the clinic early next year, Raymond tells investors in a research note. The analyst likes the deal. Achillion has already shown proof of concept in PNH and strategically the company adds to the diversification of Alexion's pipeline, says Raymond. The analyst remains a buyer of Alexion shares.
10/17/19
BOFA
10/17/19
INITIATION
Target $130
BOFA
Buy
Alexion reinstated with a Buy at BofA/Merrill
BofA/Merrill analyst Geoff Meacham reinstated coverage of Alexion Pharmaceuticals with a Buy rating and $130 price target. "Noise" around complement competition has overshadowed Alexion's "strong" fundamentals, driven by its Soliris/Ultomiris franchise, Meacham tells investors in a research note. The analyst likes the stock's risk/reward profile given the company's "differentiated" growth and "discounted" valuation.
10/18/19
LEER
10/18/19
DOWNGRADE
Target $6.3
LEER
Market Perform
Achillion acquisition by Alexion 'makes logical sense,' says SVB Leerink
SVB Leerink analyst Joseph Schwartz downgraded Achillion (ACHN) to Market Perform from Outperform with a price target of $6.30, up from $5. In a research note to investors, Schwartz says he thinks Alexion's (ALXN) proposed acquisition of Achillion makes logical sense as it brings highly complementary assets that can deliver a broader market opportunity together at a time "when the complement space could get more competitive." The analyst thinks the deal will close without any competing bids.

TODAY'S FREE FLY STORIES

BIIB

Biogen

$294.17

5.51 (1.91%)

12:33
11/22/19
11/22
12:33
11/22/19
12:33
Periodicals
Breaking Periodicals news story on Biogen »

Biogen settles Tecfidera…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Dec

  • 05

    Dec

BIIB

Biogen

$293.68

5.02 (1.74%)

12:26
11/22/19
11/22
12:26
11/22/19
12:26
Hot Stocks
Breaking Hot Stocks news story on Biogen »

Biogen rallies 3%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Dec

  • 05

    Dec

FTCH

Farfetch

$9.73

0.335 (3.57%)

12:25
11/22/19
11/22
12:25
11/22/19
12:25
Options
Farfetch Limited call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Dec

SPX

S&P 500

$0.00

(0.00%)

, SPY

SPDR S&P 500 ETF Trust

$310.63

0.34 (0.11%)

12:18
11/22/19
11/22
12:18
11/22/19
12:18
General news
Ray Dalio says WSJ wrong, Bridgewater not betting market will fall »

Ray Dalio, Co-Chief…

SPX

S&P 500

$0.00

(0.00%)

SPY

SPDR S&P 500 ETF Trust

$310.63

0.34 (0.11%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

$0.00

(0.00%)

12:17
11/22/19
11/22
12:17
11/22/19
12:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NYE

NYSE Market Internals

$0.00

(0.00%)

12:16
11/22/19
11/22
12:16
11/22/19
12:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DELL

Dell Technologies

$53.30

-0.425 (-0.79%)

12:15
11/22/19
11/22
12:15
11/22/19
12:15
Options
Dell Technologies put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

  • 02

    Dec

  • 09

    Dec

  • 09

    Dec

12:15
11/22/19
11/22
12:15
11/22/19
12:15
General news
Treasury Action: the markets are mixed with no strong directional drivers »

Treasury Action: the…

RF

Regions Financial

$16.68

0.19 (1.15%)

12:05
11/22/19
11/22
12:05
11/22/19
12:05
Options
Regions Financial call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jan

SPCE

Virgin Galactic

$7.57

-0.88 (-10.41%)

12:00
11/22/19
11/22
12:00
11/22/19
12:00
Hot Stocks
Virgin Galactic falls -10.3% »

Virgin Galactic is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    Dec

PSTG

Pure Storage

$16.24

-3.6 (-18.15%)

12:00
11/22/19
11/22
12:00
11/22/19
12:00
Hot Stocks
Pure Storage falls -18.2% »

Pure Storage is down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Dec

  • 09

    Dec

  • 12

    Dec

  • 10

    Mar

  • 11

    Mar

DAC

Danaos

$5.65

-1.68 (-22.92%)

12:00
11/22/19
11/22
12:00
11/22/19
12:00
Hot Stocks
Danaos falls -26.2% »

Danaos is down -26.2%, or…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Nov

GSX

GSX Techedu

$18.88

2.625 (16.15%)

12:00
11/22/19
11/22
12:00
11/22/19
12:00
Hot Stocks
GSX Techedu rises 16.5% »

GSX Techedu is up 16.5%,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Nov

BKE

The Buckle

$26.24

3.9 (17.46%)

12:00
11/22/19
11/22
12:00
11/22/19
12:00
Hot Stocks
The Buckle rises 17.4% »

The Buckle is up 17.4%,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Nov

SSI

Stage Stores

$4.30

0.95 (28.36%)

12:00
11/22/19
11/22
12:00
11/22/19
12:00
Hot Stocks
Stage Stores rises 27.7% »

Stage Stores is up 27.7%,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GS

Goldman Sachs

$219.83

1.6 (0.73%)

, JPM

JPMorgan

$130.91

0.95 (0.73%)

11:57
11/22/19
11/22
11:57
11/22/19
11:57
On The Fly
Fly Intel: Wall Street's top stories at midday »

Markets were mixed near…

GS

Goldman Sachs

$219.83

1.6 (0.73%)

JPM

JPMorgan

$130.91

0.95 (0.73%)

TSLA

Tesla

$332.94

-21.88 (-6.17%)

F

Ford

$8.84

0.115 (1.32%)

GM

General Motors

$35.30

0.64 (1.85%)

GPS

Gap

$16.69

0.47 (2.90%)

UBER

Uber

$29.59

0.13 (0.44%)

HIBB

Hibbett Sports

$29.00

3.93 (15.68%)

JWN

Nordstrom

$37.50

3.21 (9.36%)

SPLK

Splunk

$135.96

9.16 (7.22%)

PSTG

Pure Storage

$16.26

-3.58 (-18.04%)

FL

Foot Locker

$39.54

-1.92 (-4.63%)

WSM

Williams-Sonoma

$66.86

-1.9 (-2.76%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Nov

  • 22

    Nov

  • 02

    Dec

  • 03

    Dec

  • 04

    Dec

  • 05

    Dec

  • 09

    Dec

  • 09

    Dec

  • 12

    Dec

  • 14

    Jan

  • 15

    Jan

  • 04

    Feb

  • 10

    Mar

  • 11

    Mar

ACM

Aecom

$42.48

0.095 (0.22%)

11:55
11/22/19
11/22
11:55
11/22/19
11:55
Conference/Events
Aecom participates in a conference call with BofA/Merrill »

Aecom discusses…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Nov

  • 10

    Dec

DE

Deere

$176.24

0.18 (0.10%)

11:46
11/22/19
11/22
11:46
11/22/19
11:46
Conference/Events
Deutsche Bank machinery analysts to hold an analyst/industry conference call »

Machinery Analysts, along…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 03

    Dec

HIIQ

Health Insurance Innovations

$16.15

-0.85 (-5.00%)

11:45
11/22/19
11/22
11:45
11/22/19
11:45
Options
Health Insurance Innovations call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

HBI

Hanesbrands

$14.93

0.16 (1.08%)

11:35
11/22/19
11/22
11:35
11/22/19
11:35
Options
HanesBrands put volume heavy and directionally bearish »

Bearish flow noted in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FB

Facebook

$197.95

-0.15 (-0.08%)

11:34
11/22/19
11/22
11:34
11/22/19
11:34
Periodicals
Facebook to turn over additional docs in California privacy probe, Reuters says »

Facebook has agreed to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Nov

BA

Boeing

$368.13

1.66 (0.45%)

11:31
11/22/19
11/22
11:31
11/22/19
11:31
Hot Stocks
Boeing says SVP of Communications Anne Toulouse to step down at year-end »

Boeing announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ZTCOY

ZTE Corp.

$0.00

(0.00%)

, MU

Micron

$46.10

0.56 (1.23%)

11:30
11/22/19
11/22
11:30
11/22/19
11:30
Periodicals
Breaking Periodicals news story on ZTE Corp., Micron, Western Digital, Bought by LITE, Acacia Communications, NeoPhotonics, Lumentum, II-VI »

FCC declares Huawei, ZTE…

ZTCOY

ZTE Corp.

$0.00

(0.00%)

MU

Micron

$46.10

0.56 (1.23%)

WDC

Western Digital

$48.44

0.59 (1.23%)

OCLR

Bought by LITE

$0.00

(0.00%)

ACIA

Acacia Communications

$66.67

-0.02 (-0.03%)

NPTN

NeoPhotonics

$8.08

-0.11 (-1.34%)

LITE

Lumentum

$67.67

0.54 (0.80%)

IIVI

II-VI

$27.35

-0.11 (-0.40%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Dec

  • 03

    Dec

  • 09

    Dec

  • 09

    Dec

  • 18

    Dec

GOOG

Alphabet

$1,296.07

-5.13 (-0.39%)

, GOOGL

Alphabet Class A

$1,294.89

-4.86 (-0.37%)

11:28
11/22/19
11/22
11:28
11/22/19
11:28
Periodicals
Google denies reports claiming Stadia units experiencing overheating, Vice says »

Some Google Stadia…

GOOG

Alphabet

$1,296.07

-5.13 (-0.39%)

GOOGL

Alphabet Class A

$1,294.89

-4.86 (-0.37%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CC

Chemours

$16.44

0.2 (1.23%)

11:25
11/22/19
11/22
11:25
11/22/19
11:25
Options
Chemours call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.